Clinical Trial of an Anti-cancer Drug, CA-4948 (Emavusertib), in Combination With Chemotherapy Treatment (FOLFOX Plus Bevacizumab) in Metastatic Colorectal Cancer

Clinical trial NCT06696768 · RECRUITING

Trial details

NCT number: NCT06696768
Sponsor: National Cancer Institute (NCI)
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Metastatic Colorectal Adenocarcinoma Stage III Colorectal Cancer AJCC v8 Stage IV Colorectal Cancer AJCC v8 Unresectable Colorectal Adenocarcinoma

Start date: 2025-06-23
Primary completion: 2026-12-31
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.